Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Serine/threonine phosphatase PP2A is essential for optimal B cell function
Esra Meidan, Hao Li, Wenliang Pan, Michihito Kono, Shuilian Yu, Vasileios C. Kyttaris, Christina Ioannidis, Noe Rodriguez Rodriguez, Jose C. Crispin, Sokratis A. Apostolidis, Pui Lee, John Manis, Amir Sharabi, Maria G. Tsokos, George C. Tsokos
Esra Meidan, Hao Li, Wenliang Pan, Michihito Kono, Shuilian Yu, Vasileios C. Kyttaris, Christina Ioannidis, Noe Rodriguez Rodriguez, Jose C. Crispin, Sokratis A. Apostolidis, Pui Lee, John Manis, Amir Sharabi, Maria G. Tsokos, George C. Tsokos
View: Text | PDF
Research Article Immunology

Serine/threonine phosphatase PP2A is essential for optimal B cell function

  • Text
  • PDF
Abstract

Protein phosphatase 2A (PP2A), a serine/threonine phosphatase, has been shown to control T cell function. We found that in vitro–activated B cells and B cells from various lupus-prone mice and patients with systemic lupus erythematosus display increased PP2A activity. To understand the contribution of PP2A to B cell function, we generated a Cd19CrePpp2r1afl/fl (flox/flox) mouse which lacks functional PP2A only in B cells. Flox/flox mice displayed reduced spontaneous germinal center formation and decreased responses to T cell-dependent and T-independent antigens, while their B cells responded poorly in vitro to stimulation with an anti-CD40 antibody or CpG in the presence of IL-4. Transcriptome and metabolome studies revealed altered nicotinamide adenine dinucleotide (NAD) and purine/pyrimidine metabolism and increased expression of purine nucleoside phosphorylase in PP2A-deficient B cells. Our results demonstrate that PP2A is required for optimal B cell function and may contribute to increased B cell activity in systemic autoimmunity.

Authors

Esra Meidan, Hao Li, Wenliang Pan, Michihito Kono, Shuilian Yu, Vasileios C. Kyttaris, Christina Ioannidis, Noe Rodriguez Rodriguez, Jose C. Crispin, Sokratis A. Apostolidis, Pui Lee, John Manis, Amir Sharabi, Maria G. Tsokos, George C. Tsokos

×

Figure 1

Increased PP2A expression and enhanced function in activated B cells or B cells from lupus-prone mice and SLE patients.

Options: View larger image (or click on image) Download as PowerPoint
Increased PP2A expression and enhanced function in activated B cells or ...
(A) Western blot analysis on the expression of both scaffold (PP2AA) and catalytic (PP2AC) subunits in splenic B cells isolated from the indicated mice. Quantification of Western blots (n = 3 per experiment, a representative experiment and pooled densitometry of the 3 experiments are shown). (B) Germinal center B cells (GC, CD19+FAS+GL7+), plasma cells (PC, CD19+IgG+CD138hi), marginal zone B cells (MZ, CD19+CD21+CD23lo), and follicular B cells (FO, CD19+CD21loCD23hi) were FACS sorted for qPCR. Dot plots show the expression of PP2AA, and elevated expression was observed in GC and PC compared with MZ and FO. (C) Flow cytometry analysis of the expression of PP2Ac (indicated by mean florescence intensity, MFI) in total B cells from patients with SLE and matched healthy controls. (D) Dot plots show the increased MFI of PP2Ac in DN B cells (CD19+IgD–CD27–), memory B cells (CD19+IgD–CD27+), and plasma B cells (CD19+IgG+CD138+) compared with naive B cells (CD19+IgD+CD27–). (E–H) CD19+ human B cells were enriched by magnetic beads and cultured with the indicated stimuli for the indicated time. (E) Dot plots show the expression of PP2Aa in B cells stimulated with either CpG or anti-CD40 compared with unstimulated B cells 3 hours after stimulation. (F) Dot plots show the expression of PP2Aa in B cells stimulated with either CpG or anti-CD40 compared with unstimulated B cells 3 hours after stimulation. (G) Western blot analysis of the expression of PP2Aa and PP2Ac in human B cells stimulated with either CpG or anti-CD40 for 48 hours. (H) Dot plots show the quantification of PP2Aa and expression PP2Ac in human B cells stimulated with either CpG or anti-CD40 compared with control unstimulated B cells 3 hours after stimulation. (I and J) PP2A phosphatase activity was quantified using a kit from R&D. The activity of PP2A is presented as the rate of phosphate release (pmol × 102). (I) Bar graph shows the PP2A phosphatase activity in ex vivo splenic B cells from lupus-prone Mrl.lpr mice compared with matching control Mrl.mpj mice (data pooled from 3 independent experiments, paired t test, mean ± SEM). (J) Splenic B cells were enriched from C57BL/6J WT mice by MACS and stimulated with the indicated reagents for several time periods; kinetic curves show the PP2A phosphatase activity (n = 3 for 3 independent experiments, 2-way ANOVA analysis, mean ± SEM).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts